Free Access
Med Sci (Paris)
Volume 18, Number 11, Novembre 2002
Page(s) 1095 - 1101
Section M/S Revues : Articles de Synthèse
Published online 15 November 2002
  1. Vanherweghem JL, Depierreux M, Tielemans C, et al. Rapidly progressive interstitial renal fibrosis in young women : association with slimming regimen including Chinese herbs. Lancet 1993; 341 : 387–91. [Google Scholar]
  2. Vanhaelen M, Vanhaelen-Fastre R, But P, Vanherweghem JL. Identification of aristolochic acid in Chinese herbs. Lancet 1994; 343 : 174. [Google Scholar]
  3. Mengs U. Acute toxicity of aristolochic acid in rodents. Arch Toxicol 1987; 59 : 328–31. [Google Scholar]
  4. Jackson L, Kofman S, Weiss A, Brodovsky H. Aristolochic acid [NSC-50413] : phase I clinical study. Cancer Chemother 1964; 42 : 35–7. [Google Scholar]
  5. Vanherweghem JL. Misuse of herbal remedies : the case of an outbreak of terminal renal failure in Belgium (Chinese herbs nephropathy). J Altern Compl Med 1998; 4 : 9–13. [Google Scholar]
  6. Stephanovic V, Polenakovic MH. Balkan nephropathy : kidney disease beyond the Balkans. Am J Nephrol 1991; 11 : 1–11. [Google Scholar]
  7. Reginster F, Jadoul M, Van Ypersele De Strihou C. Chinese herbs nephropathy : presentation, natural history and fate after transplantation. Nephrol Dial Transpl 1997; 12 : 81–6. [Google Scholar]
  8. Vanherweghem JL, Cuykens JJ, Vandenbergh P, Bouman KP, Hagers Y. Valvular heart disease and Chinese herb nephropathy. Lancet 1998; 351 : 991. [Google Scholar]
  9. Gillerot G, Jadoul M, Arlt VM, et al. Aristolochic acid nephropathy in a Chinese patient : time to abandon the term « Chinese Herbs Nephropathy ». Am J Kidney Dis 2000; 38 : E 26. [Google Scholar]
  10. Pourrat J, Montastruc JL, Lacombe JL, Cisterne JM, Rascol O, Dumazer P. Néphropathie associée à des herbes chinoises : 2 cas. Presse Med 1994; 23 : 1669. [Google Scholar]
  11. Stengel B, Jones E. Insuffisance rénale terminale associée à la consommation d’herbes chinoises en France. Néphrologie 1998; 19 : 15–20. [Google Scholar]
  12. Pêna JM, Borras M, Ramos J, Montoliu J. Rapidly progressive interstitial renal fibrosis due to a chronic intake of a herb (Aristolochia pistolochia) infusion. Nephrol Dial Transpl 1996; 11 : 1359–60. [Google Scholar]
  13. Tanaka A, Nishida R, Maeda K, Sugawara A, Kuwahara T. Chinese herb nephropathy in Japan presents adult onset Fanconi syndrome : could different components of aristolochic acids cause a different type of Chinese herb nephropathy ? Clin Nephrol 2000; 53 : 301–6. [Google Scholar]
  14. Tanaka A, Nishida R, Yoshida T, Koshikawa M, Goto M, Kuwahara T. Outbreak of Chinese herb nephropathy in Japan : are there any difference from Belgium ? Intern Med 2001; 40 : 296–300. [Google Scholar]
  15. Lord GM, Tagore R, Cook T, Gower P, Pusey CD. Nephropathy caused by Chinese herbs in the UK. Lancet 1999; 354 : 481–2. [Google Scholar]
  16. Lord GM, Cook T, Arlt VM, Schmeiser HH, Williams G, Pusey CD. Urothelial malignant disease and Chinese herbal nephropathy. Lancet 2001; 358 : 1515–6. [Google Scholar]
  17. Cronin AJ, Maidment G, Cook T, et al. Aristolochic acid as a causative factor in a case of Chinese herbal nephropathy. Nephrol Dial Transpl 2002; 17 : 524–5. [Google Scholar]
  18. Yang CS, Lin CH, Chang SH, Hsu HC. Rapidly progressive fibrosing interstitial nephritis associated with Chinese herbal drugs. Am J Kidney Dis 2000; 35 : 313–8. [Google Scholar]
  19. Chang CH, Wang YM, Yang AH, Chiang SS. Rapidly progressive interstitial renal fibrosis associated with Chinese herbal medications. Am J Nephrol 2001; 21 : 441–8. [Google Scholar]
  20. Yang SS, Chu P, Lin YF, Chen A, Lin SH. Aristolochic acid-induced Fanconi’s syndrome and nephropathy presenting as hypokalemic paralysis. Am J Kidney Dis 2002; 39 : E 14. [Google Scholar]
  21. Meyer MM, Chen TP, Bennet WM. Chinese herb nephropathy. BUMC Proc 2000; 13 : 334–7. [Google Scholar]
  22. Krumme B, Endmeir R, Vanhaelen M, Walb D. Reversible Fanconi syndrome after ingestion of a Chinese herbal « remedy » containing aristolochic acid. Nephrol Dial Transpl 2001; 16 : 400–2. [Google Scholar]
  23. Cosijns JP, Jadoul M, Squifflet JP, et al. Chinese herbs nepropathy : a clue to Balkan endemic nephropathy ? Kidney Int 1994; 45 : 1680–8. [Google Scholar]
  24. Depierreux M, Van Damme B, Vanden Houte K, Vanherweghem JL. Pathologic aspects of a newly described nephropathy related to the prolonged use of Chinese herbs. Am J Kidney Dis 1994; 24 : 172–80. [Google Scholar]
  25. Mengs U, Lang W, Poch JA. The carcinogeric action of aristolochic acid in rats. Arch Toxicol 1982; 51 : 107–19. [Google Scholar]
  26. Cosyns JP, Jadoul M, Squifflet JP, Van Cangh PJ, Van Ypersele De Strihou C. Urothelial malignancy in nephropathy due to Chinese herbs. Lancet 1994; 344 : 188. [Google Scholar]
  27. Vanherweghem JL, Tielemans C, Simon J, Depierreux M. Chinese herbs nephropathy and renal pelvic carcinoma. Nephrol Dial Transpl 1995; 10 : 270–3. [Google Scholar]
  28. Cosyns JP, Jadoul M, Squifflet JP, Wese FX, Van Ypersele De Strihou C. Urothelial lesions in Chinese herb nephropathy. Am J Kidney Dis 1999; 33 : 1011–7. [Google Scholar]
  29. Nortier J, Muniz Martinez MC, Schmeiser HH, et al. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N Engl J Med 2000; 342 : 1686–92. [Google Scholar]
  30. Cosyns JP, Goebbels RM, Liberton V, Schmeiser HH, Bieler CA, Bernard AM. Chinese herbs nephropathy associated slimming regimen induces tumours in the forestomach but not interstitial nephropathy in rats. Arch Toxicol 1998; 72 : 738–43. [Google Scholar]
  31. Cosyns JP, Dehoux JP, Guiot Y, et al. Chronic aristolochic acid toxicity in rabbits : a model of Chinese herb nephropathy ? Kidney Int 2001; 59 : 2164–73. [Google Scholar]
  32. Debelle FD, Nortier J, Deprez E, et al. Aristolochic acids induce chronic renal failure with interstitial fibrosis in salt depleted rats. J Am Soc Nephrol 2002; 13 : 431–6. [Google Scholar]
  33. Muniz Martinez MC, Nortier J, Vereerstraeten P, Vanherweghem JL. Progression rate of Chinese herb nephropathy : impact of Aristolochia fangchi ingested dose. Nephrol Dial Transpl 2002; 17 : 408–12. [Google Scholar]
  34. Kabanda A, Jadoul M, Lauwerys R, Bernard A, Van Ypersele De Strihou C. Low molecular weight proteinuria in Chinese herbs nephropathy. Kidney Int 1995; 48 : 1571–6. [Google Scholar]
  35. Nortier JL, Deschodt-Lanckman MM, Simon S, et al. Proximal tubular injury in Chinese herb nephropathy : monitoring by neutral endopeptidase enzymuria. Kidney Int 1997; 51 : 288–93. [Google Scholar]
  36. Tanaka A, Nishida R, Yokoi H, Kuwahara T. The characteristic pattern of aminoaciduria in patients with aristolochic acid-induced Fanconi syndrome : could iminoaciduria be the hallmark of this syndrome ? Clin Nephrol 2000; 54 : 198–202. [Google Scholar]
  37. Lebeau C, Arlt VM, Schmeiser HH, et al. Aristolochic acid impedes endocytosis and induces DNA adducts in proximal tubule cells. Kidney Int 2001; 60 : 1332–42. [Google Scholar]
  38. Arlt VM, Pfohl-Leszkowicz A, Cosyns JP, Schmeiser HH. Analyses of DNA adducts formed by ochratoxin A and aristolochic acid in patients with Chinese herbs nephropathy. Mutat Res 2001; 494 : 143–50. [Google Scholar]
  39. Schmeiser HH, Bieler CA, Wiessler M, Van Ypersele De Srihou C, Cosyns JP. Detection of DNA adducts formed by aristolochic acid in renal tissue from patients with Chinese herbs nephropathy. Cancer Res 1996; 56 : 2025–8. [Google Scholar]
  40. Stiborova M, Frei E, Wiessler M, Schmeiser HH. Human enzymes involved in the metabolic activation of carcinogenic aristolochic acids : evidence for reductive activation by cytochromes P4501A1 and 1A2. Chem Res Toxicol 2001; 14 : 1128–37. [Google Scholar]
  41. Schmeiser HH, Scherf HR, Wiessler M. Activating mutations at codon 61 of the c-Ha-ras gene in thin tissue sections of tumors induced by aristolochic acid in rats and mice. Cancer Lett 1991; 59 : 139–43. [Google Scholar]
  42. Vanherweghem JL, Abramowicz D, Tielemans C, Depierreux M. Effects of steroids on the progression of renal failure in chronic interstitial renal fibrosis : a pilot study in Chinese herb nephropathy. Am J Kidney Dis 1996; 27 : 209–15. [Google Scholar]
  43. Stiborova M, Frei E, Breuer A, Wiessler M, Schmeiser HH. Evidence for reductive activation of carcinogenic aristolochic acids by prostaglandin H synthetase- 32P- postlabeling analysis of DNA adduct formation. Mutat Res 2001; 493 : 149–60. [Google Scholar]
  44. Vanherweghem JL. Aristolochia sp and chronic interstitial nephropathies in Indians. Lancet 1997; 349 : 1399. [Google Scholar]
  45. Vanherweghem JL. Nephropathy and herbal medicine. Am J Kidney Dis 2000; 35 : 330–2. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.